LIBERTY PARTNERS GROUP, LLC

Lobbying for ANGIOSAFE (CARDIOVASCULAR COALITION) · Manufacturer of products to treat peripheral artery disease.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · posted Apr 17, 2026

Lobbying activity 2

Medicare/Medicaid

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Health Issues

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.